Nectar Lifescience Ltd (NECLIFE) — Voting Results | 18 September 2026
Nectar Lifesciences shareholders approved all five AGM resolutions, including adoption of FY2026 standalone and consolidated financial statements, re-appointment of three directors, and appointment of a new non-executive director, with voting results showing overwhelming support across all categories.
About Nectar Lifescience Ltd (NECLIFE)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when NECLIFE files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track NECLIFE — Free💡 Ask AI about this filing
📊 More NECLIFE filings
- Announcement — 24 September 2026Nectar Lifesciences announced that its trading window closes on October 1, 2026, and remains shut un...
- 🟡 Board Meeting — 19 September 2026Nectar Lifesciences held its 31st AGM on September 18, 2026, approving the 2025-26 standalone financ...
- 🔴 Annual Report — 22 August 2026Nectar Lifesciences announced the 2025-26 Annual Report and upcoming AGM on September 18, 2026, acce...
- 🟡 Board Meeting — 20 August 2026Nectar Lifesciences Limited announced its 31st AGM on September 18, 2026, via video conference, with...
- 🟡 Board Meeting — 15 August 2026Nectar Lifesciences announced a board-approved change of its corporate office from Chandigarh's Plot...
🔥 Also filed on 18 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when NECLIFE files new disclosures
Track NECLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track NECLIFE — FreeFree account · 2 AI queries/day